Aastrom Biosciences Inc. (ASTM) announced the pricing of underwritten public offering of 46.154 million units at a public offering price of $0.26 per unit. Each unit consists of one share of common stock, a Class A Warrant to purchase 0.75 of a share of common stock and a Class B Warrant to purchase 0.50 of a share of common stock.
Each whole Class A Warrant entitles the holder to acquire one common share of the company upon payment of $0.3718 per share, exercisable for a five year period commencing on a date six months after the closing date of the offering.
Each whole Class B Warrant entitles the holder to acquire one common share of the Company upon payment of $0.26 per share, exercisable for a six month period commencing on the closing date of the offering.
The company has granted the underwriter a 30-day over-allotment option to purchase up to 6,923,100 shares of common stock, Class A Warrants to purchase 5,192,325 shares of common stock and/or Class B Warrants to purchase 3,461,550 shares of common stock.
The offering is expected to close on January 21.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.